Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease
- PMID: 21388375
- PMCID: PMC3127285
- DOI: 10.1111/j.1471-4159.2011.07237.x
Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease
Abstract
In addition to progressive dementia, Alzheimer's disease (AD) is characterized by increased incidence of seizure activity. Although originally discounted as a secondary process occurring as a result of neurodegeneration, more recent data suggest that alterations in excitatory-inhibitory (E/I) balance occur in AD and may be a primary mechanism contributing AD cognitive decline. In this study, we discuss relevant research and reports on the GABA(A) receptor in developmental disorders, such as Down syndrome, in healthy aging, and highlight documented aberrations in the GABAergic system in AD. Stressing the importance of understanding the subunit composition of individual GABA(A) receptors, investigations demonstrate alterations of particular GABA(A) receptor subunits in AD, but overall sparing of the GABAergic system. In this study, we review experimental data on the GABAergic system in the pathobiology of AD and discuss relevant therapeutic implications. When developing AD therapeutics that modulate GABA it is important to consider how E/I balance impacts AD pathogenesis and the relationship between seizure activity and cognitive decline.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.
Similar articles
-
GABA(A) receptors in aging and Alzheimer's disease.J Neurochem. 2007 Nov;103(4):1285-92. doi: 10.1111/j.1471-4159.2007.04832.x. Epub 2007 Aug 20. J Neurochem. 2007. PMID: 17714455 Review.
-
Impaired Expression of GABA Signaling Components in the Alzheimer's Disease Middle Temporal Gyrus.Int J Mol Sci. 2020 Nov 18;21(22):8704. doi: 10.3390/ijms21228704. Int J Mol Sci. 2020. PMID: 33218044 Free PMC article.
-
Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's disease.Cell Mol Neurobiol. 2003 Oct;23(4-5):491-505. doi: 10.1023/a:1025063811290. Cell Mol Neurobiol. 2003. PMID: 14514010
-
Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy.Int J Mol Sci. 2021 Jul 1;22(13):7133. doi: 10.3390/ijms22137133. Int J Mol Sci. 2021. PMID: 34281185 Free PMC article. Review.
-
GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited.Brain Res Bull. 1998;45(4):341-79. doi: 10.1016/s0361-9230(97)00347-x. Brain Res Bull. 1998. PMID: 9527011 Review.
Cited by
-
Optimal gamma-band entrainment of visual cortex.Hum Brain Mapp. 2024 Jul 15;45(10):e26775. doi: 10.1002/hbm.26775. Hum Brain Mapp. 2024. PMID: 38970249 Free PMC article.
-
GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study.Neuropsychobiology. 2024;83(1):17-27. doi: 10.1159/000535512. Epub 2023 Dec 27. Neuropsychobiology. 2024. PMID: 38151012 Free PMC article.
-
Aging affects GABAergic function and calcium homeostasis in the mammalian central clock.Front Neurosci. 2023 May 16;17:1178457. doi: 10.3389/fnins.2023.1178457. eCollection 2023. Front Neurosci. 2023. PMID: 37260848 Free PMC article.
-
Generation of Urine-Derived Induced Pluripotent Stem Cells and Cerebral Organoids for Modeling Down Syndrome.Stem Cell Rev Rep. 2023 May;19(4):1116-1123. doi: 10.1007/s12015-022-10497-8. Epub 2023 Jan 18. Stem Cell Rev Rep. 2023. PMID: 36652145
-
Cell type characterization of spatiotemporal gene co-expression modules in Down syndrome brain.iScience. 2022 Dec 28;26(1):105884. doi: 10.1016/j.isci.2022.105884. eCollection 2023 Jan 20. iScience. 2022. PMID: 36647384 Free PMC article.
References
-
- Armstrong DM, Sheffield R, Mishizen-Eberz AJ, Carter TL, Rissman RA, Mizukami K, Ikonomovic MD. Plasticity of glutamate and GABAA receptors in the hippocampus of patients with Alzheimer's disease. Cell. Mol. Neurobiol. 2003;23:491–505. - PubMed
-
- Backus KH, Arigoni M, Drescher U, Scheurer L, Malherbe P, Mohler H, Benson JA. Stoichiometry of a recombinant GABAA receptor deduced from mutation-induced rectification. Neuroreport. 1993;5:285–288. - PubMed
-
- Ballard TM, Knoflach F, Prinssen E, et al. RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors. Psychopharmacology (Berl) 2009;202:207–223. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- NS055371/NS/NINDS NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- AG005131/AG/NIA NIH HHS/United States
- R01 AG032755/AG/NIA NIH HHS/United States
- AG032755/AG/NIA NIH HHS/United States
- U01 AG010483/AG/NIA NIH HHS/United States
- PN2 EY016525/EY/NEI NIH HHS/United States
- R01 NS066072/NS/NINDS NIH HHS/United States
- R01 AG032755-03/AG/NIA NIH HHS/United States
- EY016525/EY/NEI NIH HHS/United States
- NY066072/PHS HHS/United States
- PN1 EY016525/EY/NEI NIH HHS/United States
- R01 NS055371/NS/NINDS NIH HHS/United States
- AG010483/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical